On January 17, 2023, BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) announced that in addition to the US Provisional Patent Application with serial number 63/297,009 that was filed on January 6, 2022, covering the monitoring and controlling aspects of its EZ-G device, the company filed a full-scale PCT application on January 5, 2023, under serial number PCT/IL2023/050016.
The PCT application is based on BYND Cannasoft’s prototype of the EZ-G device that is currently under development and its operational aspects as a learning adult device. The PCT application further claims priority from the US Provisional application and covers an adult device with a structure and one or more moving and vibrating elements.
In addition to potentially treating annoying phenomena in the female reproductive system, the EZ-G device includes technological advancements as a sex toy with a more realistic experience. The EZ-G device prototype uses sensors like a pressure sensor, temperature sensor, conductivity sensor, and heart rate sensor to determine what specifically enhances the users’ pleasure.
The EZ-G device uses artificial intelligence (AI) to transmit and receive data from the device’s sensors on conditions of the user’s sexual organs, such as moisture levels and pressure variations due to muscle contraction. The EZ-G prototype includes a Bluetooth component for controlling the adult device via an app installed on a smartphone or other portable device to collect user information about preferences and generate custom programs.
The data collected from the sensors is uploaded to the secured cloud, where it is combined with other antonymic user preferences, including the actual duration of operation of the adult device, lubrication level, and the ideal vibration level.
This information optimizes the operation of the device to satisfy the user sexually. The EZ-G device uses the collected secure data to learn the users’ responses and improve its operation to bring the user sexual satisfaction.
Wearable tech has seen tremendous growth in recent years. When most people think of wearables, they think of fitness trackers and smartwatches, but there is also an emerging trend in wearable sex toys.
The excitement of a sex toy and the thrill of clandestine public stimulation have contributed to this trend. Cannasoft intends to take advantage of the growth in the sextech market, which is expected to reach $62.32Bn by 2030.
According to Forbes, companies are working to innovate products that have an intelligent response to sexual activity to take advantage of this expected growth.
Yftah Ben Yaackov, CEO and Director of BYND Cannasoft said:
"The EZ-G device has evolved to provide treatment relief from sexual and mental problems, including the ability to have intercourse as it relates to anxiety and physical pain. The device is capable of enhancing sexual pleasure and reducing sexual pain by dispensing low concentrations of C-B-D oil lubricant in a controlled manner. It could be configured to use disposable capsules that include the C-B-D lubricant, which could be dispensed in accordance with data collected by the sensors. The sale of the disposable capsules containing the C-B-D lubricant would provide BYND Cannasoft with a revenue model much like the razor and the razor blade."
Find more key company details here.
And right now, BCAN has several potential catalysts to soak in right now. Check them out:
No. 1 BCAN Potential Catalyst - Low Float Volatility Could Approach Quickly In A Blink
According to the Yahoo Finance website, BCAN has a low float.
The website reports this profile to have approximately 2.46Mn shares in its float.
Why is that important? It's important on one crucial level. Volatility.
Could more positive company news ahead of 2024 provide a near term spark?
No. 2 BCAN Potential Catalyst - War In Gaza Has Company Creating New Plan Of Work Focusing On Proprietary CRM Platform
Israeli Ministry of Health Reports Surge in Medical Cann-a-bis ("CB") Patients Following Recent Events
ASHKELON, Israel and VANCOUVER, British Columbia, Nov. 07, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”), announced today a new plan of work that focuses on its proprietary CRM platform in an effort to help meet the increased demand for medical CB in Israel. Recent regulatory reforms approved by the Israeli Ministry of Healthi allows physicians to prescribe CB to patients as a first-line treatment rather than as an option of last resort. Israel has had a significant increase in the number of licensed medical CB patientsii in the wake of recent events, particularly the opening of the war in Gaza. This surge has resulted in more than 2,000 new patients in just one month, approaching the peak numbers of 2021 and bringing the total number to over 132,000 as of November 2023. BYND Cannasoft’s proprietary Benefit CRM enables small and medium-sized enterprises to optimize day-to-day functions, such as sales management, workforce management, contact center operations, and asset management. Benefit CRM is provisioned as SaaS to some of Israel's most recognizable companies.
As part of the new plan of work, the software development phase will focus on innovative elements in the field of artificial intelligence that will increase their data collection and analysis.
Physicians licensed to prescribe medical CB and Israeli Ministry of Health authorities have reported a notable surge in demand after the recent conflict. There is a burgeoning presence of initiatives by both corporate entities and private individuals aimed at providing CB to individuals residing in the southern region. The increasing trend comes after a period of data stagnation in the first half of the year. The Israeli medical community is experiencing a tremendous increase in the number of patients seeking treatment for post-trauma, marking a significant shift from the previous decline in this category.
In February 2023, BYND Cannasoft announced that the Medical CB Unit at the Ministry of Health of the State of Israel issued the Company a full license to engage in medical CB without direct contact with the substance. This license allows BYND Cannasoft to trade in medical CB products through an agreement with a licensed CB grower in Israel. The recent increase in patients seeking treatment for post-trauma, which had seen a decline in the past year, adds significant value to this license, as well as BYND Cannasoft’s proprietary CRM platform.
"Israel is a small country, and although we continue to take a business-as-usual approach, every one of us is directly impacted, either personally or through our family and loved ones. BYND Cannasoft supports and stands with all of the Israelis affected by this tragedy. In Israel, the CB and pharmaceuticals industries are part of the critical infrastructure sector, and I am very proud of how the team is coming together to work through this horrific situation," said Yftah Ben Yaackov, CEO and Director of BYND Cannasoft. "While we continue to develop our EZ-G device for the recreational market, and potentially as an FDA-approved medical device, our decision to refocus on CB will benefit our shareholders, as well as those impacted by the war who are seeking treatment from psychiatric and pain clinics. We are grateful to be in this position to help our country and its people."
Read the full article here.
No. 3 BCAN Potential Catalyst - Positive Momentum Hits Quickly With Website Launch (Product Demand Grows)
Thousands of Early Registrations Flood in for EZ-G Device in the First Few Weeks Since Website Launch
Vancouver, British Columbia - TheNewswire - October 11, 2023 - BYND Cannasoft Enterprises Inc. (Nasdaq:BCAN) (CSE:BYND) (“BYND Cannasoft” or the “Company”), is pleased to announce today that within the first few weeks since the launch of its website, thousands of visitors have registered on the website. Registration allows a person to place orders for the EZ-G devices once they are ready to be delivered. This surge reflects the great demand for the innovative product and underscores the company's commitment to delivering its technology to customers.
BYND Cannasoft is poised to take full advantage of this positive response by expanding its marketing efforts to tap into Foria's vast customer base, comprising hundreds of thousands of loyal patrons. The company expects this strategic move to result in thousands of additional orders soon, thereby solidifying the EZ-G device's market presence.
The Company’s business model for the EZ-G device is not solely reliant on the sale of the product. It also incorporates a subscription-based model for capsules containing C-B-D oil, hemp seed oil, and other natural oils on a monthly basis following the well-established monthly subscription-based model, popularized by direct-to-consumer subscription services for razors and blades. This novel approach ensures ongoing revenue streams and creates a sustainable, long-term relationship with customers.
“We are thrilled by the tremendous response to the EZ-G Device within the first week since our website's launch,” said Yftah Ben Yaackov, CEO and Director of BYND Cannasoft. “The thousands of early registrations speak volumes about the demand for this innovative product, reaffirming our commitment to delivering cutting-edge technology to our valued customers. Expanding our marketing efforts to reach Foria's extensive customer base is a strategic move that we believe will yield thousands of additional orders in the near future, further establishing the EZ-G device in the market. We are grateful for the interest in our device, and we remain dedicated to bringing real positive change to women’s health market.”
Read the full article here.
No. 4 BCAN Potential Catalyst - New MOU With Women's Wellness Innovator Points To Big Things Ahead
BYND Cannasoft Enterprises Inc. and Foria Announce Memorandum of Understanding for Collaborative Ventures in Female Wellness Industry
First joint opp. involves the manufacturing by Foria of the EZ-G Device therapeutic capsules
Vancouver, British Columbia - TheNewswire - September 26, 2023 - BYND Cannasoft Enterprises Inc. (Nasdaq:BCAN) (CSE:BYND) (“BYND Cannasoft”),..., today announced the signing of a Memorandum of Understanding (MOU) outlining plans to form a strategic alliance to enhance the understanding and collaborate on opp's available in the fast growing female wellness industry.
Originally launched in 2014 to fill long-standing unmet needs in the sexual wellness market, Foria sets the standards for clean, innovative and highly effective formulas. The alliance plans to integrate Foria’s knowledge and experience in the sexual wellness space, along with the brand’s beloved organic botanical and C-B-D-based products, with BYND Cannasoft’s patent pending EZ-G therapeutic solution device, which utilizes AI to help address women’s health issues. Foria’s team plans to develop oil capsules designed for use in BYND Cannasoft’s EZ-G Devices, which leverage proprietary software to regulate the flow of low concentrations of C-B-D oil, hemp seed oil, and other natural oils into the soft tissues of the female reproductive system. The device is expected to provide users with a personalized experience that meets various needs related to sexual pleasure and potentially address a wide variety of women’s health issues.
“At BYND Cannasoft, we are thrilled to announce this collaboration with Foria,” says Yftah Ben Yaackov, CEO and Director of BYND Cannasoft. “Foria has long been an innovator in the women’s sexual health and wellness market, incorporating the benefits of C-B-D and other natural oils into their products, so partnering with them to create the pods needed for our EZ-G Device is an exciting opp. This partnership is another affirmation of our commitment to delivering exceptional products and experiences to our customers.”
Read the full article here.
BCAN Recap - The Top Potential Breakout Catalysts To Know Right Now
No. 1 - Low Float Volatility Could Approach Quickly In A Blink
No. 2 - War In Gaza Has Company Creating New Plan Of Work Focusing On Proprietary CRM Platform
No. 3 - Positive Momentum Hits Quickly With Website Launch (Product Demand Grows)
No. 4 - New MOU With Women's Wellness Innovator Points To Big Things Ahead
Coverage is officially reinitiated on BCAN. When time permits, do this: